The International Diabetes Federation (IDF) projects a continual rise in diabetes cases, estimating over 460 million people affected globally as of 2020. This expanding patient base underscores a growing market for diabetes-related medications and technologies.
The onset of Type 2 diabetes in younger demographics, including children and adolescents, is shifting the landscape, creating a need for long-term treatment solutions and patient education
Diabetes mellitus, commonly referred to as diabetes, is a chronic metabolic disorder characterized by elevated blood sugar levels over a prolonged period. It is a global health concern affecting millions of people worldwide and is associated with significant morbidity, mortality, and healthcare costs. Diabetes arises from either the body's inability to produce enough insulin or the ineffective use of the insulin it produces
What is Teneligliptin 20 + Metformin 500?
Teneligliptin 20 + Metformin 500 is a combination medication used to manage type 2 diabetes. It combines two active ingredients: teneligliptin and metformin. Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, while metformin is a biguanide. This combination helps control blood sugar levels by targeting different mechanisms in the body.
How Does Teneligliptin 20 + Metformin 500 Work?
Teneligliptin 20 + Metformin 500 works in two ways to help manage type 2 diabetes:
By combining these two medications, Teneligliptin 20 + Metformin 500 provides a dual-action approach to managing type 2 diabetes, helping to improve overall glycemic control.
Benefits of Teneligliptin 20 + Metformin 500
Talk to your doctor to know more on REUGLIPT M
REUEL PHARMACEUTICALS
52/3216 - A Vembully Lane, Vyttila, Cochin, Ernakulam, Kerala 682019 | Kootezhath Bldg, Kuvempu Layout, Hebbal-Kempapura, Bangalore-560024
Copyright © 2024 REUEL PHARMACEUTICALS - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.